Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C8024)
◆英語タイトル:Sol-Gel Technologies Ltd (SLGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8024
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The company’s pipeline products include vered, twin and sirs-t drug candidates. Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne. Sol-Gel’s vered drug candidate is a topical encapsulated benzoyl peroxide cream developed for the treatment of papulopustular rosacea. The company’s sirs-t drug candidate is topical encapsulated tretinoin cream developed for the potential treatment of acne. It also develops silica-based microencapsulation technology platform. Sol-Gel is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd (SLGL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sol-Gel Technologies Enters into Agreement with Perrigo Israel Pharma 11
Sol-Gel Technologies Enters into Agreement with CMO 12
Sol-Gel Technologies Amended Development Agreement with Perrigo 13
Licensing Agreements 14
Douglas Pharma Enters into Licensing Agreement with Sol-Gel Technologies 14
Sol-Gel Technologies Enters Into Licensing Agreement With US-Based Pharma Company For Dermatologic Drug 15
Equity Offering 16
Sol-Gel Tech Raises USD86.3 Million in IPO of Shares 16
Acquisition 18
Mori Arkin Plans to Acquire Sol-Gel for USD10 Million 18
Sol-Gel Technologies Ltd – Key Competitors 19
Sol-Gel Technologies Ltd – Key Employees 20
Sol-Gel Technologies Ltd – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
May 15, 2018: Sol-Gel Technologies Announces First Quarter 2018 Financial Results 22
Mar 26, 2018: Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results 23
Corporate Communications 25
Sep 13, 2018: Sol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors 25
Clinical Trials 26
Feb 15, 2018: Sol-Gel presents Phase 2 Data on VERED at the 2018 American Academy of Dermatology Annual Meeting 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sol-Gel Technologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sol-Gel Technologies Enters into Agreement with Perrigo Israel Pharma 11
Sol-Gel Technologies Enters into Agreement with CMO 12
Sol-Gel Technologies Amended Development Agreement with Perrigo 13
Douglas Pharma Enters into Licensing Agreement with Sol-Gel Technologies 14
Sol-Gel Technologies Enters Into Licensing Agreement With US-Based Pharma Company For Dermatologic Drug 15
Sol-Gel Tech Raises USD86.3 Million in IPO of Shares 16
Mori Arkin Plans to Acquire Sol-Gel for USD10 Million 18
Sol-Gel Technologies Ltd, Key Competitors 19
Sol-Gel Technologies Ltd, Key Employees 20

List of Figures
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報(Sol-Gel Technologies Ltd (SLGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆